Westat   Report issue

For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rockville MD United States (1963)

Organization Overview

First Clinical Trial
1991
NCT00000590
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Mathematical Statistician, Westat | Westat | Westat, Inc

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 3)

Atrophy (Phase 2)

Communicable Diseases (Phase 2)

HIV Infections (Phase 3)

Immunologic Deficiency Syndromes (Phase 3)

Infections (Phase 2)

Muscular Atrophy (Phase 2)

Muscular Atrophy, Spinal (Phase 2)

Paralysis (Phase 2)

Spinal Muscular Atrophies of Childhood (Phase 2)

Supranuclear Palsy, Progressive (Phase 2)

Tuberculosis (Phase 3)

Urinary Tract Infections (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 25
  • # of Trial APIs: 37